Aurora Investment Counsel Buys Shares of 60,267 Waystar Holding Corp. $WAY

Aurora Investment Counsel bought a new stake in Waystar Holding Corp. (NASDAQ:WAY) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 60,267 shares of the company’s stock, valued at approximately $1,974,000.

A number of other institutional investors also recently made changes to their positions in WAY. Royal Bank of Canada raised its position in shares of Waystar by 11.3% in the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after purchasing an additional 2,195 shares in the last quarter. AQR Capital Management LLC acquired a new position in shares of Waystar in the 1st quarter valued at approximately $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Waystar by 91.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after purchasing an additional 22,364 shares in the last quarter. NewEdge Advisors LLC acquired a new position in shares of Waystar in the 1st quarter valued at approximately $234,000. Finally, Goldman Sachs Group Inc. raised its position in shares of Waystar by 13.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock valued at $27,918,000 after purchasing an additional 88,256 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on WAY shares. Deutsche Bank Aktiengesellschaft cut their target price on Waystar from $42.00 to $37.00 and set a “buy” rating on the stock in a research report on Thursday, March 12th. Loop Capital set a $33.00 target price on Waystar in a research report on Wednesday, February 18th. UBS Group cut their target price on Waystar from $41.00 to $37.00 and set a “buy” rating on the stock in a research report on Thursday, April 30th. Canaccord Genuity Group dropped their price target on Waystar from $54.00 to $30.00 and set a “buy” rating on the stock in a research report on Wednesday, February 18th. Finally, Barclays dropped their price target on Waystar from $36.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 20th. Three research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $35.62.

Waystar Stock Performance

WAY stock opened at $18.75 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37. The firm has a market cap of $3.60 billion, a P/E ratio of 27.99, a P/E/G ratio of 0.74 and a beta of 0.10. Waystar Holding Corp. has a 12-month low of $17.89 and a 12-month high of $41.47. The stock’s 50 day simple moving average is $21.48 and its 200 day simple moving average is $26.21.

Waystar (NASDAQ:WAY) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.03. The business had revenue of $313.87 million for the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The business’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. As a group, equities research analysts predict that Waystar Holding Corp. will post 1.46 EPS for the current year.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.